IQVIA Safety & Regulatory Compliance’s Post

With PV teams allocating 40 to 85% of budgets towards case processing, cutting-edge AI is transforming pharmacovigilance. From reducing case processing costs to slashing timelines, AI is rewriting the rules for efficiency and accuracy. In this week's Expert View, IQVIA’s Uwe Trinks examines the impact of new artificial intelligence-based tools on the pharma industry. Read more: https://bit.ly/4jatjN3 #AIInPharma #PharmaInnovation #AutomationInsights

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics